← Browse by Condition
Medical Condition

cystic fibrosis cf

Total Trials
8
Recruiting Now
8
Trial Phases
Phase 3, Phase 2

ClinicalMetric tracks all active clinical trials for cystic fibrosis cf sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — cystic fibrosis cf Clinical Trials

How many clinical trials are currently recruiting for cystic fibrosis cf?
ClinicalMetric currently tracks 8 actively recruiting clinical trials for cystic fibrosis cf, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 8. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for cystic fibrosis cf?
cystic fibrosis cf research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a cystic fibrosis cf clinical trial?
Eligibility criteria for cystic fibrosis cf trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
Boston Children's Hospital 1 trial
Sheffield Teaching Hospitals NHS Foundation Trust 1 trial
Thomas Jefferson University 1 trial
Papworth Hospital NHS Foundation Trust 1 trial
Indiana University 1 trial

Recruiting Clinical Trials

NCT07031323
Recruiting
OnTrackCF: Engagement, Feasibility, and Acceptability Study
Enrollment
60 pts
Location
United States
Sponsor
Boston Children's Hospital
View Trial →
NCT07192679
Recruiting
MAGNIFY - Pulmonary Magnetic Resonance Imaging for Cystic Fibrosis
Enrollment
60 pts
Location
United Kingdom
Sponsor
Sheffield Teaching Hospitals N...
View Trial →
NCT07436351
Recruiting
ACT With CF Self-Help Toolkit
Enrollment
60 pts
Location
United States
Sponsor
Thomas Jefferson University
View Trial →
NCT07289100
Recruiting
Novel Sensors and Artificial Intelligence for Detection of Acute Pulmonary Exacerbations in Cystic Fibrosis and Bronchiectasis
Enrollment
50 pts
Location
United Kingdom
Sponsor
Papworth Hospital NHS Foundati...
View Trial →
NCT06996951 Phase 3
Recruiting
Sinonasal Therapies and Histologic Correlations of Patients With Cystic Fibrosis in the Era of Highly Effective Modulator Therapy
Enrollment
64 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT07303621
Recruiting
Population Pharmacokinetics of Elexacaftor-tezacaftor-ivacaftor in a Paediatric Population
Enrollment
150 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT06998043 Phase 2
Recruiting
Study With Phage for CF Subjects With Pseudomonas Lung Infection
Enrollment
63 pts
Location
United States
Sponsor
BiomX Ltd
View Trial →
NCT06915961
Recruiting
Epididymis Protein 4 and Pulmonary Function With Quality Improvement Protocol Among Cystic Fibrosis Patients
Enrollment
35 pts
Location
Egypt
Sponsor
Ain Shams University
View Trial →

Related Conditions

cystic fibrosis complete (1) depressive and anxiety disorders (1) psychological flexibility (1) bronchiectasis adult (1) chronic rhinosinusitis crs (1) chronic pseudomonas aeruginosa infection (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology